TY - JOUR
T1 - Research on human embryos and reproductive materials
T2 - Revisiting canadian law and policy
AU - Ogbogu, Ubaka
AU - Zarzeczny, Amy
AU - Baltz, Jay
AU - Bedford, Patrick
AU - Du, Jenny
AU - Hyun, Insoo
AU - Jaafar, Yasmeen
AU - Jurisicova, Andrea
AU - Kleiderman, Erika
AU - Koukio, Yonida
AU - Knoppers, Bartha Maria
AU - Leader, Arthur
AU - Master, Zubin
AU - Nguyen, Minh Thu
AU - Noohi, Forough
AU - Ravitsky, Vardit
AU - Toews, Maeghan
N1 - Funding Information:
This paper is the outcome of a workshop funded by the Stem Cell Network of Canada, with additional support from the University of Alberta Faculty of Law and the McGill Centre of Genomics and Policy, and is part of a larger research grant also funded by the Stem Cell Network. Ubaka Ogbogu is the grant holder and Ubaka Ogbogu and Amy Zarzeczny are the principal investigators. The views expressed in the paper are those of the authors and not those of any governmental or non-governmental organizations.
Funding Information:
We would like to acknowledge and thank the following workshop participants: Janetta Bijl (Stem Cell Network), Stanislav Birko (University of Montreal), Wendy Burgess (Secretariat on Responsible Conduct of Research, Panel on Research Ethics), Alana Cattapan (University of Saskatchewan), Eric M. Meslin (Council of Canadian Academies), Peter Monette (Health Canada), Cate Murray (Stem Cell Network), Kyle Norrie (Health Canada), Cathy Parker (Health Canada), Lynne Scholten (Canadian Institutes of Health Research), Anu Shukla-Jones (Health Canada) and Susan Zimmerman (Secretariat on Responsible Conduct of Research, Panel on Research Ethics).
PY - 2018
Y1 - 2018
N2 - Research involving human embryos and reproductive materials, including certain forms of stem cell and genetic research, is a fast-moving area of science with demonstrated clinical relevance. Canada's current governance framework for this field of research urgently requires review and reconsideration in view of emerging applications. Based on a workshop involving ethics, legal, policy, scientific and clinical experts, we present a series of recommendations with the goal of informing and supporting health policy and decision-making regarding the governance of the field. With a pragmatic and principled governance approach, Canada can continue its global leadership in this field, as well as advance the long-Term health and well-being of Canadians.
AB - Research involving human embryos and reproductive materials, including certain forms of stem cell and genetic research, is a fast-moving area of science with demonstrated clinical relevance. Canada's current governance framework for this field of research urgently requires review and reconsideration in view of emerging applications. Based on a workshop involving ethics, legal, policy, scientific and clinical experts, we present a series of recommendations with the goal of informing and supporting health policy and decision-making regarding the governance of the field. With a pragmatic and principled governance approach, Canada can continue its global leadership in this field, as well as advance the long-Term health and well-being of Canadians.
UR - http://www.scopus.com/inward/record.url?scp=85045770562&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045770562&partnerID=8YFLogxK
U2 - 10.12927/hcpol.2018.25401
DO - 10.12927/hcpol.2018.25401
M3 - Review article
C2 - 29595433
AN - SCOPUS:85045770562
VL - 13
SP - 10
EP - 19
JO - Healthcare Policy
JF - Healthcare Policy
SN - 1715-6572
IS - 3
ER -